John T McDevitt
Professor, Departments of Bioengineering & chemistry
Rice University, USA
McDevitt has written and coauthored more than 170 peer reviewed scientific manuscripts and written more than 150 patents and patent applications. His individual honors include the Presidential Young Investigator Award and the Exxon Education Award. McDevitt cofounded LabNow an Austinbased startup to commercialize lab on a chip diagnostic technology in 2004. McDevitt serves as the Principal Investigator for 6 major clinical trials involving the programmable bionanochip for major diseases in the areas of cardiac heart disease oral cancer ovarian cancer and prostate cancer. He has recently established the Texas Cancer Diagnostics Pipeline and serves as the Director for the newly formed Early Disease Detection Gulf Coast Consortium Cluster thereby creating a network of over 100 clinical researchers devoted to next generation of affordable diagnostics.
Nanomedicine; Integrated lab-on-a-chip sensors; Clinical chemistry; Point of care diagnostics; Affordable healthcare; Micro-electro-mechanical (MEMs) devices; Cardiovascular disease; Saliva-based diagnostics; Cancer diagnostics; Infectious diseases; Pathogen detection; Cell imaging systems; image-based sensors; Multi-class (combined cellular, Genomic, Proteomic, general chemistry panels) multi-plexed sensor systems.